$1.54
0.3327.16%
Last update: Nov 9, 2:50 PM
Inovio Pharmaceuticals Inc
INONASDAQ
The average analyst price target for Inovio Pharmaceuticals is $14.56, 842.4% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $4 to $40. The latest change came on Nov 6, 2026, when Jefferies raised its price target on Inovio Pharmaceuticals from $3 to $8 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
